Agartala: Chief Minister Prof. Dr. Manik Saha inaugurated the Emicizumab Programme for people living with severe Haemophilia A at the IGM Hospital Complex in Agartala. The programme has been organised by the Department of Health and Family Welfare, Government of Tripura, to support patients affected by this inherited bleeding disorder.
The initiative aims to strengthen access to specialised treatment for patients affected by this inherited bleeding disorder and improve their long-term healthcare support.
Haemophilia A is a genetic condition caused by a deficiency of clotting factor VIII, which makes it difficult for blood to clot normally. People with severe Haemophilia A are at risk of recurrent bleeding episodes, including bleeding into joints and muscles, which can lead to serious complications if not properly managed.
Emicizumab is a preventive medicine designed to reduce bleeding episodes in people with Haemophilia A. It works by helping restore part of the blood-clotting process and is administered through an injection under the skin. Unlike conventional factor VIII replacement therapy, it does not require frequent intravenous administration.
The launch of the programme marks an important development in efforts to improve access to specialised care for people living with severe Haemophilia A in Tripura.


